Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Group 1 (ages 50 to 80):
- People who are currently not using tobacco products.
- People who identify as East Asian (including Chinese, Japanese, Korean, Taiwanese, or Malaysian), Southeast Asian (including Cambodian, Thai, Vietnamese, or Filipino), or Hispanic/Latinx (including those of Cuban, Puerto Rican, Dominican, or other Central or South American or Caribbean origin — not including people originally from Spain).
- For parts of the study involving surveys or tests: people who can read and understand consent forms in English, Mandarin, Cantonese, Japanese, Korean, Vietnamese, Spanish, Portuguese, or Cape Verdean.
- For the focus group part of the study: people who can read, understand, and speak in English, Mandarin, Vietnamese, or Spanish.
Group 2 (ages 40 to 49):
- People who are currently not using tobacco products and identify as East Asian, Southeast Asian, or Hispanic/Latinx, AND who meet at least one of the following conditions:
- A family member has been diagnosed with a specific type of lung cancer linked to gene changes called EGFR L858R or exon 19 (confirm with trial site).
- A personal history of a cancer other than lung cancer or certain chest-area cancers, as long as it was fully resolved more than 5 years ago.
- A history of tuberculosis (TB), asthma that requires daily inhaled medication, or chronic bronchitis.
- Symptoms in the past month that may include coughing up blood, unexplained weight loss, a hoarse voice, a new or worsening cough, or new or worsening shortness of breath.
- For parts of the study involving surveys or tests: people who can read and understand consent forms in English, Mandarin, Cantonese, Japanese, Korean, Vietnamese, Spanish, Portuguese, or Cape Verdean.
- For the focus group part of the study: people who can read, understand, and speak in English, Mandarin, Vietnamese, or Spanish.
Who may not be able to join:
- People who have had a chest CT scan in the past 3 years, or who are expecting to have one during the time the trial is enrolling.
- People who currently have cancer, or who have had cancer within the last 5 years (certain minor skin cancers and a specific non-invasive breast condition may be exceptions — confirm with trial site).
- People who have smoked or used tobacco for a total of more than 400 cigarettes (roughly 20 packs) over their lifetime.
- People who are not able to provide informed consent on their own.
- People under 40 years of age.
- People who are currently in prison.
- People who are pregnant.
- People who have personally been diagnosed with lung cancer.
- People who are not able to meet the requirements of the study.
- People in Group 2 who currently have fever, a cold, flu, COVID-19, RSV, adenovirus infection, a runny nose, sore throat, or a cough producing green or yellow mucus.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Narjust Florez, MD, Dana-Farber Cancer Institute
Phone: 857-215-2795
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection Rate of Non-Small Cell Lung Cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.